x#review 

non-TH2
neutrophil mediated
CRSsNP

# Reference


“In general, LDLT macrolide for the treatment of CRS is known to act on non-type 2 inflammation with low levels of eosinophils and immunoglobulin (Ig) E [16].” ([Ryu et al., 2023, p. 2](zotero://select/library/items/DG9XSUBY)) ([pdf](zotero://open-pdf/library/items/AXBUKUTZ?page=2&annotation=9WBAY6KC))

[[non eCRS]]

[image] ([pdf](zotero://open-pdf/library/items/AXBUKUTZ?page=3&annotation=25GX725J))  
([Ryu et al., 2023, p. 3](zotero://select/library/items/DG9XSUBY))